Real-time SEC alerts Start Free →
Profitelligence
Kenvue Inc.
KVUE LOW Impact

Kenvue Inc.

Kenvue Inc. Reports Financial Results for Q2 2024

| 8-K |Consumer Defensive

Summary

On August 6, 2024, Kenvue Inc. announced its financial results for the fiscal second quarter ended June 30, 2024. The announcement included details on the company's earnings and financial condition, although specific figures were not detailed in the 8-K content. Kenvue also furnished financial statements and exhibits, which were not attached to this filing.

Profitelligence Profitelligence Alerts

Get alerts for KVUE

Be first to know when Kenvue Inc. files with the SEC.

Set Up Alerts →

Filing Categories

General Statement Exhibits Furnished

Exhibits (1)

Advertisement

About Kenvue Inc.

Kenvue Inc. is a consumer healthcare and pharmaceutical company. It focuses on delivering a range of health-centric products, spanning hygiene, pain relief, and other wellness categories. With deep-rooted expertise in pharmaceuticals, Kenvue Inc. targets the health and wellness needs of individuals, providing both prescription and over-the-counter solutions. The company has established itself as a vital entity in the consumer health sector, significantly impacting community health standards and individual lives. Positioned in the pharmaceutical industry, Kenvue Inc. collaborates with healthcare providers to enhance its product reach and efficacy. Its broad portfolio includes well-known brands and formulations that are trusted globally by consumers seeking reliable health solutions. As a player in this sector, Kenvue Inc. contributes to the enhancement of public health, highlighting its prominence in both domestic and international markets.

Exchange: NYSE Industry: Household & Personal Products Company Website →

Official SEC Documents

KVUE
KVUE Research
8Ks, insider trades, financials, technicals
SEC Alert Manager
Get alerts within 60 seconds of new filings

Advertisement